Sporos Bioventures
Alex Cranberg is an active early-stage biotech investor with strong ties to the Texas and Houston biotech ecosystem. Alex is the Chairman and Founder of the Board of Aspect Management Corporation, which manages the Aspect family of companies. Aspect is a global enterprise, which has invested over $1 billion in energy exploration and production activities. Alex is also an active biotech investor in several early-stage companies. He served on The University of Texas System Board of Regents and also on the Board of the Texas Medical Center. He holds an M.B.A. from Stanford University and a degree in petroleum engineering from University of Texas at Austin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sporos Bioventures
Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC) and reach across the industry, the Company identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease.